Background: In earlier studies based on selected populations, the relative risk for thyroid
INTRODUCTION
Celiac disease (CD) is a lifelong immune-mediated disorder that is triggered by gluten exposure in genetically sensitive individuals (1) . Gluten is present in wheat, rye and barley.
CD has been linked to a number of complications such as osteoporosis (2) , adverse pregnancy outcome (3), and hematologic disease (4). Recently, we and others have shown that individuals with CD are at increased risk of certain cancers (5-7), especially lymhoproliferative malignancies (8).
Thyroid cancer (TC) is often diagnosed after detection of a nodule or mass in the neck and ultrasound guided biopsy, or on a histopathologic examination after partial thyroidectomy.
More advanced TC may present with pain and voice involvement. The most common subtype of TC is papillary TC (PTC). Many reports have linked CD and thyroid disease (including autoimmune thyroiditis) (9-17), but few studies have been conducted on CD and the risk of future TC (18-21). We have identified three studies reporting relative risks of TC in CD, but numbers were small and the relative risks varied between 0. 6 and 22.5 (19-21) , and a fourth study that did not calculate relative risk estimates (18) .
Considering this uncertainty, we decided to carry out a population-based study examining the risk of TC in a nationwide cohort of Swedish patients with biopsy-verified CD.
Based on the findings of the two most recent papers where study participants were adults (and therefore at greater risk of developing TC) (20, 21), we hypothesized that biopsy-verified CD would be positively associated with TC.
METHODS
We linked data on CD from biopsy reports (22) obtained from Sweden's 28 pathology departments to data on TC in the Swedish Cancer Register (23). Linkages were made possible through the personal identity number (24) assigned to all Swedish residents. Table 1) . Validation of VA has since shown a positive predictive value of 95% for CD (22).
Although we did not require a positive CD serology for the CD diagnosis, earlier medical records reviews have shown that 88% of individuals with VA and available CD serology data were serologically positive at the time of biopsy (22). Each individual undergoing biopsy was matched with up to 5 reference individuals through the Total Population Register (matching criteria were age, sex, county and calendar year).
In this study, we used the same CD cohort (n=29,096) and matched reference individuals (n=144,522) as in our previous study investigating mortality in CD (25). We then excluded individuals with a diagnosis of TC before CD diagnosis and study entry (22 individuals with CD and 82 controls), as well as an additional 40 controls whose index individual with CD had been excluded (all analyses were performed stratumwise).
Outcome
Our main outcome was a diagnosis of any TC (international classification of disease, ICD7 code=194 in the Swedish Cancer Register). In our definition of any TC we excluded cases of medullary TC (pathology code "186") because medullary TC is a genetic TC variant and therefore highly unlikely to be associated with CD.
In separate analyses we also examined the risk of PTC defined as: a) ICD7=194, This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. 
Statistics
Hazard ratios (HRs) for TC were estimated through internally stratified Cox regression. In internally stratified Cox regression, each index individual with CD was compared only with his or her reference individuals within the same stratum. A summary risk estimate was then calculated on the basis of all stratum-specific results. In this way we eliminated the influence of sex, age, calendar year and county. The proportional hazards assumption was tested through plotting log minus log curves (available upon request).
Expected numbers of TC cases were calculated as the observed number of cases divided by the HR. Hence the expected number was based on age-and sex-matched data from our general population control cohort, rather than from national trend data. In pre-defined subanalyses we calculated the HR for TC according to follow-up, age and calendar year at CD diagnosis. We had initially intended to estimate HRs for both male and female patients with CD but because of the lack of TC cases in male patients, we calculated only the risk of TC in female patients. Incidence rates as the number of first recorded TC events divided by person-years at risk (PYAR) are given in Tables 2 and 3. Although type 1 diabetes mellitus has not been linked to the risk of TC (26) we chose to adjust for "any diabetes" because a recent paper found a non-significant association between self-reported diabetes and TC (27), and CD has been linked to type 1 diabetes This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. mellitus (28). We also adjusted for hyperparathyroidism because this disorder has been linked to CD (29) , and individuals with hyperparathyroidism may be at increased risk of discovery of TC on neck examination.
We used relevant ICD-codes to identify individuals with any diabetes, and hyperparathyroidism in the Swedish Patient Register. In separate analyses we also adjusted for education and country of birth (Nordic country vs. non-Nordic country). These co-variates may potentially influence health care consumption and the chance of having TC diagnosed.
We used SPSS 18.0 to perform all analyses. HRs with 95% CIs that did not include a value of 1 were regarded as statistically significant.
Ethics
The study was approved by the Research Ethics Committee of Karolinska Institutet.
Since none of the participants was contacted and individual information was anonymized prior to the analyses, informed consent was not required by the Research Ethics Committee.
RESULTS
The study sample consisted of 29,074 individuals with CD and 144,400 reference individuals matched for sex, age, calendar year and county. Some 62% of study participants were female ( Table 1 ). The median age at CD diagnosis was 30 years.
CD and any TC
During follow-up there were 7 cases of TC vs. an expected 12. All 7 cases of TC in CD occurred in women. The incidence of any TC in this population was 2.1/100,000 PYAR compared with 3.5/100,000 PYAR in reference individuals. The HR for any TC in CD was 0.6 (95%CI=0.3-1.3) and did not vary more than marginally with follow-up after diagnosis This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. 7 (Table 2) . Adjusting risk estimates for any diabetes, country of birth or education did not affect risk estimates (data not shown), nor was the risk estimate affected by the presence of hyperparathyroidism (data not shown). Excluding the first year of follow-up, the HR remained 0.6 (95%CI=0.2-1.3), and we found similar risk estimates within the first five years after celiac diagnosis, and thereafter (Table 2 ). When the analysis was restricted to females, the association between CD and TC remained null (HR 0.7; 95%CI=0.3-1.5). Because of the lack of TC in male patients with CD we could not estimate any HR in this group. Risk estimates were similar for each calendar period (until 1999: HR=0.6; and 2000 and onwards: HR=1.1)( Table 3 ; p for interaction between CD and calendar period=0.823). Risk estimates were similar in CD patients diagnosed before or after age 25 years (Table 3 , p for interaction between CD and age at celiac diagnosis=0.691).
In a post-hoc analysis, we examined TC incidence according to calendar year of celiac diagnosis. The incidence rate of TC in individuals diagnosed with CD until 1999 was 5/247,651 PYAR (2.0/100,000 PYAR) vs. 43/1,247,493 PYAR (3.5/100,000 PYAR). The TC incidence rate in individuals diagnosed with CD from year 2000 or later was 2/78,654 PYAR (2.5/100,000 PYAR) vs. 14/393,935 PYAR (3.6/100,000 PYAR).
CD and PTC
The HR for PTC was 0.7 (95%CI=0.3-1.8), based on 5 cases vs. 7 expected ( Table 2 ).
The incidence of PTC in this population was 1.5/100,000 PYAR compared with 2.2/100,000 PYAR in reference individuals. The HRs for PTC were similar in the first five years after celiac diagnosis and thereafter ( Table 2) .
As was the case with TC overall, HRs did not change with adjustment for any diabetes, country of birth or education (data not shown). Risk estimates for PTC were almost identical to those for any TC with regards to female patients with CD), and according to age at CD This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
diagnosis as well as calendar period (data not shown).

DISCUSSION
This study found no increased risk of any TC or of PTC in patients with CD. We linked nationwide data on biopsy-verified CD from more than 29,000 patients with CD to the Swedish Cancer Register. The Cancer Register was established in 1958 and has a virtually 100% coverage.
Earlier literature
While Schweizer et al. found more TC cases in children (n=3) than expected (18), they were unable to calculate a relative risk of TC because of the lack of reference individuals.
Askling et al. did not find any risk increase for TC in patients with CD (standardized incidence ratio=0.6; 95%CI=0.0-3.3) (19). but 73% of their study participants were also children so potentially very few individuals with CD reached an age when TC is prevalent. In addition, their 95%CI did not rule out a substantially increased risk of TC (Askling et al.
found 1 case with TC vs. an expected=1.7 cases) (19). In contrast, two recent studies reported increased risks of TC (20, 21). An Italian collaborative study of 1757 patients with CD found a 2.5-fold increased risk of PTC (20) The discrepancies between the results of the current study and that of Volta et al. (20) and Kent et al. (21) may be attributable to different study designs and how cases with CD were ascertained. In addition both these studies were based on patients followed in specialist centers for their CD and thereby were more than likely being examined on a frequent basis. This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
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To avoid the risk of selection bias we used biopsy registers to identify patients with CD in this study; patients identified in referral centers may have a more severe disease than the average patient and this increase in disease severity can increase the estimate for complications. More than 96% of Swedish pediatricians and gastroenterologists will biopsy at least 90% of patients with CD (22). Although VA may be caused by other diseases than CD, in a Swedish setting VA has a very high positive predictive value for CD, as demonstrated in a previous validation study (22). When two independent researchers evaluated more than 1500 biopsy reports, other diseases than CD were only rarely mentioned in the biopsy reports (0.3% of VA reports mentioned inflammatory bowel disease) (22).
From an international perspective the incidence of TC in this study was low in both CD patients and controls. This is probably accounted for by the high number of children who participated in the study (lower absolute risk of TC), but may also be attributable to the low national rates for TC in Sweden (30).
Potential limitations
It is unlikely that the null association between CD and TC was attributable to low statistical power. Although the number of actual TC cases in our study was small this was mostly because of the lack of positive association between CD and any TC. The expected number of cases with TC in our study was 12 (compared to 1.7 in Askling et al. (19) ; 0.13 in Kent et al. (21); and 2.4 in Volta et al. (20) ). The expected number of TC in adults was 10 during a follow-up of 179,065 PYAR. This corresponds to an incidence of 5.6/100,000 PYAR in adults, which is consistent with international estimates (31).
We did not have data on dietary adherence in patients with CD. This is a minor shortcoming since we found no increased risk of TC in CD. This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
We also had no data on body mass index (BMI) or smoking. Obesity is positively associated with TC (32), but inversely related to CD (33). Different body mass index in CD patients and controls may therefore have contributed to the non-significantly lower risk of TC seen in our cohort of CD patients. Although we lacked data on smoking, smoking is unlikely to explain the neutral relationship seen in this study as most studies suggest that smoking is inversely related both to thyroid cancer (34) and CD (35).
We were unable to examine the relative risk of TC in male patients with CD. To explore the lack of cases we went back to our original dataset from the Swedish Cancer Register where TC cases were obtained for this study. In that dataset we found a female-tomale ratio of 3:1 in TC cases, consistent with earlier research (36). We therefore believe the lack of TC in male patients with CD was due to insufficient power in this subgroup analysis, especially given the female predominance of CD in this database. The lack of TC cases in male patients with CD is however consistent with the main finding of this study, that Swedish patients with biopsy-verified CD were at no increased risk of TC.
In conclusion, this study found no association between CD and TC. This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. 
